Abstract:
Benzenesulfonylureas (I; X = 2-quinolyl, 4-methyl-2-quinoyl, 2-pyridyl, R = Me, Et, Pr, R1 = alkyl, cycloalkyl, cycloalkylmethyl, Benzyl) were prepd. by heating 5.6g 4-(β-N'- 2-quinolyl-N'-methylureidoethyl)-benzenesulfonylmethylcarbamate and a mixt. of 1.lg cyclopentylamine and 75ml dioxane. When I was administered orally to rabbits at 10mg/kg, the blood sugar level was decreased by 4.3% after one hr, 49% after 24hr, and 18% after 47hr.
Abstract:
The title compds. (I; X=pyridyl, pyrimidinyl, quinolyl, benzthiazolyl, benzoxazolyl; R=C1-3 alkyl; R1=C3-6 alkyl, C5-9 cycloalkyl, alkylcycloalkyl, cycloalkenyl, bicycloheptyl, bicycloheptenyl, ada-antyl, benzyl) were prepd. by hydrolysis of II (A=urea substitutent such as isourea ether). Thus, N-4-(-(N'-methvl-N'-2-pyridyl-ureido)-ethyl) benzenesulfonyl-N'-cyclohexyl thiourea was treated with HgO, COCl2 and conc. HCl to geve I(X=pyridyl; R=Me; R1=C6H11) which at 10mg/kg orally in rabbits decreased the blood sugar level by 43%, after 1 hr, 49% after 24 hr and 18% after 48 hr
Abstract:
R1 represents hydrogen, lower molecular alkyl, acyl, phenyl, R2 is hydrogen, lower molecular alkyl, R3 is alkyl having 3 to 6 carbon atoms, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkenyl, alkylcycloalkenyl having each 5 to 9 carbon atoms, cyclohexenylmethyl, chlorocyclohexyl, bicycloheptenylmethyl, bicycloheptylmethyl, bicycloheptenyl, bicycloheptyl, nortricyclyl, adamantyl, benzyl, phenylethyl, which as substance or in the form of their salts have pypoglycemic properties and which are distinguished by a strong and continuous lowering of the blood sugar level; processes for preparing them as well as pharmaceutical preparations containing the sulfonyl-ureas as an active substance.
IN WHICH X represents hydrogen, chlorine, bromine, methoxy or methyl, Y represents -CH(CH3)-CH2-, -CH2-CH(CH3)-or preferably -CH2-CH2-, Z represents hydrogen or together with Y and the phenylene radical the radical
WHICH IN THE FREE FROM OR IN THE FORM OF THEIR SALTS HAVE BLOOD SUGAR LOWERING PROPERTIES AND ARE DISTINGUISHED BY A STRONG AND LONG-LASTING HYPOGLYCEMIC ACTION. IN THE FORMULA X REPRESENTS (R-O-),Z-PHENYL OR 3-(R-O-),5-Z''-THIEN-2-YL WHEREIN R STANDS FOR AN ALKYL GROUP HAVING 1 TO 4 CARBON ATOMS, Z STANDS FOR A HALOGEN ATOM, AN ALKYL OR ALKOXY GROUP BOTH HAVING 1 TO 4 CARBON ATOMS, AND Z'' STANDS FOR A HALOGEN ATOM OR AN ALKYL GROUP HAVING 1 TO 4 CARBON ATOMS.
Abstract:
1. A BENZENE-SULFONYL SEMICARBAZIDE OF THE FORMULA 1-(R-CO-NH-Y-),4-(R1-NH-CO-NH-SO2-)BENZENE WHEREIN R REPRESENTS (A) PHENYL WHICH MAY CARRY ONE OR TWO SUBSTITUENTS SELECTED FROM THE GROUP CONSISTING OF LOWER ALKYL, LOWER ALKENYL, LOWER ALKOXY, LOWER ALKENOXY, LOWER ALKOXYALKOXY, ACETYL, HALOGEN, TRIFLUORO-METHYL, OR THE METHYLENE-DIOXY GROUP, (B) THIENYL WHICH MAY CARRY ONE OR TWO SUBSTITUENTS SELECTED FROM THE GROUP CONSISTING OF HALOGEN, LOWER ALKYL, LOWER ALKOXY LOWER ALKENYLOXY LOWER ALKOXYALKOXY, PHEN-LOWERALKOXY, OR POLYMETHYLENE CHAIN CONTAINING FROM 3 TO 4 CARBON ATOMS, LINKED AT ITS TWO ENDS TO THE THIENYL GROUP, Y REPRESENTS -CH2-CH2-, -CH2-CH-(CH3)OR -CH-(CH3)-CH2-, R1 REPRESENTS 4,7-ENDOALKYLENE-HEXAHYDRO-ISO-INDOLINE OR 4,7-ENDOALKYLENE-TETRAHYDRO-ISO-INDOLINE, HAVING 1 TO 2 CARBON ATOMS IN THE ENDOALKYLENE GROUP, IN THE CASE OF TETRAHYDROCOMPOUNDS THE DOUBLE LINKAGE DEING IN 5,6-POSITION; 4,7-ENDOCYCLOBUTYLENE-HEXAHYDROISO-INDOLINE; 4,7-ENDOCYCLOBUTYLENE-&5-TETRAHYDRO-ISOINDOLINE; 4,7-ENDOCYCLOBUTYLENE-&5 -TETRAHYDRO-SIOINDOLINE; OR 4,7-ENDOCYCLOPROPYLENE-HEXAHYDRO-ISOINDOLINE; AND SALTS THEREOF FORMED FROM PHARMACEUTICALLY ACCEPTABLE BASES.
Abstract:
N-(4-(B-BENZAMIDO-ETHYL)-BENZENESULFONYL) -N''(ENDOALKYLENECYCLOHEXYL- OR CYCLOHEXENYL)-UREAS BEING SUBSTITUTED AT THE BENZAMIDO GROUP AND HAVING HYPOGLYCEMIC ACTIVITY AND USEFUL FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND USED IN A METHOD FOR LOWERING BLOOD SUGAR LEVEL IN THE TREATMENT OF DIABETES MELLITUS.
Abstract:
BENZENESULFONYL UREA COMPOUNDS THAT ARE EFFECTIVE AS ORAL ANTIDIABETIC AGENTS ARE DISCLOSED TO HAVE THE FORMULA
(4-(X-N(-X1)-CO-NH-Y-)PHENYL)-SO2-NH-CO-NH-R
WHEREIN R IS (A) ALKYL OR ALKENYL OF 3-6 CARBON ATOMS, (B) ENDOALKYLENE-CYCLOHEXYL, ENDOALKYLENE-CYCLOHEXENYL, ENDOALKYLENE-CYCLOHEXYLMETHYL OR ENDOALKYLENE-CYCLOHEXENYLMETHYL OF 1-2 ENDOALKYLENE CARBON ATOMS, (C) BENZYL, PHENYLETHYL, (D) CYCLOHEXYL METHYL, (E) LOWER ALKYL CYCLOHEXYL OR DIALKYL CYCLOHEXYL, METHYL CYCLOPENTYL, (F) CYCLOALKYL OF 5-8 CARBON ATOMS IN THE RING (G) CYCLOHEXENYL, CYCLOHEXENYL-METHYL, METHYLCYCLOHEXENYL, OR (H) NORTRICYCLYL,
X-N(-X1)-
IS INDOLINO OR TETRAHYDROQUINOLINO, AND Y IS ALKYLENE OF 1 TO 3 CARBON ATOMS.
WHEREIN X IS HYDROGEN, CHLORINE, BROMINE, METYL OR METHOXY, Y IS -CH(CH3)-CH3-, PREFERABLY
-CH2-CH2-,
Z IS HYDROGEN OR A HYDROCARBON RADICAL OF 1 OR 2 CARBON ATOMS, WHICH FORMS TOGETHER WITH A 5- OR 6-MEMBERED RING, R IS ALKYLENE-IMINO OF 3 TO 7 CARBON ATOMS IN THE RING WHICH MAY BE UNSATURATED OR SUBSTITUTED BY 1 OR 2 METHYL OR LOWER ALKYL OR METHOXY, PENTAMETHYLENIMINO SUBSTITUTED BY ENDOALKYLENE OF 1 TO 3 CARBON ATOMS, HEXAMETHYLENE-IMINO SUBSTITUTED BY ENDOETHYLENE IN B-EPOSITIONS, TETRAHYDRO-ISO-INDOLINE, 4,7 - ENDOALKYLENE-HEXAHYDRO- OR -TETRAHYDRO-ISO-INDOLINE, THE ENDOALKYLENE CONTAINING 1 OR 2 CARBON ATOMS AND THE DOUBLE BOND OF THE TETRAHYDRO COMPOUND BEING IN 5,6 POSITION, AND THE SALTS THEREOF.